Epstein File EFTA02455520: Harris, Surveillance and Killed (DS11)

Epstein Index›Documents›EFTA02455520

⚡IMPACT LEVEL 3 — NOTEWORTHY

Epstein File EFTA02455520: Harris, Surveillance and Killed (DS11)

General DocumentDate unavailableEFTA024555202 keyword hits

0

views

0

shares

0

reactions

1

persons

2

keywords

6

excerpts

This document discusses pharmaceutical post-marketing surveillance and drug safety, referencing FDA approval processes and the dangers of unapproved drugs. It cites statistics about drug-related deaths over an 80-year period and advocates for enhanced national surveillance databases including genomic data. The document's connection to the Epstein case is not evident from the excerpts provided.

👤 Named in This Document

Kamala Harris

🔑 Evidence Keywords

surveillance killed

📋 Key Excerpts6

PersonKeyword

Excerpt 1

Grandfathered drugs are still marketed over eighty years after first appearing without safety or efficacy data, or any form of post marketing **surveillance**

Excerpt 2

A national database of robust post-marketing **surveillance**, including genomics, would greatly enhance public health and safety and should be an integral

Excerpt 3

Even if the drug subsequently fails after post-marketing **surveillance**, it contributes to future progress.